Assessment of residual risk of atherosclerotic CVD according to serum TG and HDL-cholesterol levels and role of fenofibrate in the residual risk reduction in T2DMAssessment of residual risk of atherosclerotic CVD according to serum TG and HDL-cholesterol levels and role of fenofibrate in the residual risk reduction in T2DM
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
145 Anam-ro, Seongbuk-gu, Seoul, 02841, Korea+82-2-3290-2963
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.